Investor Type | Firm |
Industries | BioTech |
Stages | Grant, Series D, Series B, Post-IPO Equity, Private Equity, Series A, Seed |
Investing | United States |
Investment Range | $165,000,000 - $165,000,000 |
Soros Fund Management is a privately owned family office and investment firm with a rich history dating back to its establishment in 1969. They operate on a global scale, deploying significant resources across public equity and fixed income markets, as well as in the realm of private equity and venture capital. Over the years, they have expanded their reach to incorporate a diverse range of investment activities, gravitating towards a concentration in the BioTech industry amongst others. The fund is particularly known for its involvement in later-stage financing, offering growth capital across Series A, Series B, Series D, and Post-IPO Equity rounds, as well as initiating Seed investments. With a notable specialty in Grant investments, they focus on strategic growth opportunities, fostering innovation and development within their chosen fields. As befits their status and strategy, Soros Fund Management's investment size is quite specific, with both a minimum and maximum investment cap set at $165,000,000, illustrating their appetite for significant, influential stakes in their portfolio companies. In managing both private equity and venture capital funds, they strive to leverage their vast experience and resources to add value to and procure growth in the companies they invest in, especially those focused on energy, resources, and the burgeoning field of BioTech.